Company · CIK 0002023658 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Bicara Therapeutics Inc. · BCAX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 10, 4:23 pm EDT | Ryan CohlheppPresident, COO & Interim CEO, Director | 17,500 | $22.90 | $400,716 | 181,641 | −8.79% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 10, 4:23 pm EDT | Ryan CohlheppPresident, COO & Interim CEO, Director | 17,500 | $3.79 | $66,322 | 199,141 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 4:23 pm EDT | Ryan CohlheppPresident, COO & Interim CEO, Director | 17,500 | — | — | 34,252 | — | 10b5-1 |